Catalent Cts is a finished-dose manufacturer based in United States. It appears in 17 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with INVIMA (CO), ARCSA (EC) and NPRA (MY). Its GMP standing is certified by ANVISA (Brazil), MHRA (UK) and NCELS (KZ). Its most recent recorded inspection, by US FDA, closed on 4 March 2022 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Kansas City, United Arab Emirates | Not on file |
| BATHGATE, United Kingdom | Not on file |
| SWINDON, United Kingdom | Not on file |
| United Kingdom, United Kingdom | 3009442470 |
| KANSAS CITY, United States | Not on file |
| Kansas City, United States | 3002929455 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| INVIMA (CO) | 4 | None |
| ARCSA (EC) | 4 | None |
| NPRA (MY) | 3 | None |
| NCELS (KZ) | 2 | 1 |
| DIGEMAPS (DO) | 1 | None |
| EDE (AE) | 1 | None |
| ANVISA (Brazil) | None | 9 |
| MHRA (UK) | None | 6 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Catalent Cts comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.